As of 2025-06-22, the Fair Value of Clearside Biomedical Inc (CLSD) is -1.98 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.84 USD, the upside of Clearside Biomedical Inc is -336.06%.
With the market price of 0.84 USD and our fair value calculation, Clearside Biomedical Inc (CLSD) is not a good investment. Investing in CLSD stocks now will result in a potential loss of 336.06%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -18.21 | 0.38 | -32.95 | -32.49 | -34.35 | -23.52 |
| YoY growth | 40.82% | 102.09% | -8,771.05% | 1.41% | -5.75% | -1,726.50% |
| Market Cap (mil) | 65.26 |
| P/E | |
| Forward P/E |
| EPS | -0.40 |
| Avg earnings growth rate | -1,726.50% |
| TTM earnings | -30.81 |